Nutex Health (NASDAQ:NUTX) Shares Gap Down - Time to Sell?

Key Points

• Nutex Health Inc. (NASDAQ:NUTX) shares gapped down before the market opened, starting at $108.00 after a previous close of $111.13, and last traded at $90.30.
• Analysts have mixed ratings for NUTX, with Maxim Group significantly raising its target price from $100.00 to $225.00 while Wall Street Zen downgraded their rating from "strong-buy" to "buy."
• The company reported quarterly earnings of $2.56 per share, beating estimates and significantly increasing revenue to $211.79 million compared to expectations of $81.09 million.

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $111.13, but opened at $108.00. Nutex Health shares last traded at $90.30, with a volume of 72,548 shares trading hands.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on NUTX shares. Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Benchmark boosted their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Finally, Maxim Group boosted their price objective on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of "Buy" and an average price target of $262.50.

Nutex Health Price Performance

The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02. The firm's 50-day moving average is $108.23 and its 200-day moving average is $101.31. The company has a market cap of $527.98 million, a PE ratio of 7.99 and a beta of 0.05.

Institutional Investors Weigh In On Nutex Health

Several hedge funds have recently bought and sold shares of NUTX. Topline Capital Management LLC bought a new position in shares of Nutex Health in the fourth quarter worth approximately $5,690,000. Marshall Wace LLP lifted its position in Nutex Health by 333.4% during the second quarter. Marshall Wace LLP now owns 94,548 shares of the company's stock valued at $11,770,000 after purchasing an additional 72,734 shares during the period. Divisadero Street Capital Management LP bought a new position in Nutex Health during the second quarter valued at approximately $7,481,000. Geode Capital Management LLC increased its holdings in Nutex Health by 116.8% during the second quarter. Geode Capital Management LLC now owns 78,859 shares of the company's stock valued at $9,819,000 after buying an additional 42,484 shares during the last quarter. Finally, Ancora Advisors LLC purchased a new stake in Nutex Health during the fourth quarter valued at approximately $1,334,000. Institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.